Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15207021)

  • 1. Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer.
    Amador ML; Hidalgo M
    Clin Colorectal Cancer; 2004 May; 4(1):51-62. PubMed ID: 15207021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer.
    Snyder LC; Astsaturov I; Weiner LM
    Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S71-80. PubMed ID: 16336752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of small-molecule tyrosine kinase inhibitors targeting epidermal growth factor receptor in colorectal cancer.
    Kuo T; Fisher GA
    Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S62-70. PubMed ID: 16336751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the epidermal growth factor receptor in the treatment of colorectal carcinoma.
    Waxman ES; Herbst RS
    Semin Oncol Nurs; 2002 May; 18(2 Suppl 2):20-9. PubMed ID: 12053861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
    Efferth T
    Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of epidermal growth factor receptor-targeted antibody therapy in previously treated colorectal cancer.
    Watkins D; Cunningham D
    Clin Colorectal Cancer; 2007 Oct; 6 Suppl 2():S47-52. PubMed ID: 18021487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
    Kendall A; Lord R; Maisey N
    Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):142-51. PubMed ID: 19954416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions.
    Starling N; Cunningham D
    Curr Opin Oncol; 2004 Jul; 16(4):385-90. PubMed ID: 15187895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor-targeted therapy in colorectal cancer.
    O'dwyer PJ; Benson AB
    Semin Oncol; 2002 Oct; 29(5 Suppl 14):10-7. PubMed ID: 12422309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives.
    Spano JP; Fagard R; Soria JC; Rixe O; Khayat D; Milano G
    Ann Oncol; 2005 Feb; 16(2):189-94. PubMed ID: 15668269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer.
    De Pauw I; Wouters A; Van den Bossche J; Peeters M; Pauwels P; Deschoolmeester V; Vermorken JB; Lardon F
    Pharmacol Ther; 2016 Oct; 166():71-83. PubMed ID: 27373506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.
    Ruzzo A; Graziano F; Canestrari E; Magnani M
    Curr Cancer Drug Targets; 2010 Feb; 10(1):68-79. PubMed ID: 20088793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor as a target for chemotherapy.
    Vallbohmer D; Lenz HJ
    Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S19-27. PubMed ID: 15871762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting EGFR in pancreatic cancer treatment.
    Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
    Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.
    Tedesco KL; Lockhart AC; Berlin JD
    Curr Treat Options Oncol; 2004 Oct; 5(5):393-403. PubMed ID: 15341677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?
    Ponz-Sarvisé M; Rodríguez J; Viudez A; Chopitea A; Calvo A; García-Foncillas J; Gil-Bazo I
    World J Gastroenterol; 2007 Nov; 13(44):5877-87. PubMed ID: 17990353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidermal growth factor receptor as a target for colorectal cancer therapy.
    Lockhart AC; Berlin JD
    Semin Oncol; 2005 Feb; 32(1):52-60. PubMed ID: 15726506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-targeted therapies in colorectal cancer.
    Overman MJ; Hoff PM
    Dis Colon Rectum; 2007 Aug; 50(8):1259-70. PubMed ID: 17566832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies.
    Zhang W; Gordon M; Lenz HJ
    Ann Med; 2006; 38(8):545-51. PubMed ID: 17438669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.